Skip to content
Home/Companies/Biotech/hutchmed

hutchmed

Biotech·China·Active
Entry
–
Hold
–
Status
Active

Who owns hutchmed?

hutchmed is a Chinese Biotech company, currently owned by The Carlyle Group and General Atlantic.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
The Carlyle Group
Most recent investor
The Carlyle Group
Carlyle Asia Partners III · 2008 · Growth
2 ownership periods · full history below

Key facts

HQChina
SectorBiotech

Ownership history

2 ownership periods

Active
Co-held by The Carlyle Group and General Atlantic.
The Carlyle Group
The Carlyle GroupActive
present · Carlyle Asia Partners III · 2008 · Growth
General Atlantic
General AtlanticActive
present · General Atlantic Portfolio · Buyout

More from Carlyle Asia Partners III

Other portfolio companies in the same fund.

Global Health Private Limited
Exited
HealthcareIndia
HCP
Active
IndustrialsUS
Highway Roop Precision Technologies Limited
Highway Roop Precision Technologies Limited
Active
IndustrialsIndia
Livingstone
Livingstone
Exited
Business ServicesChina
to Trustmarque Solutions Limited
Prima Solutions SA
Exited
SaaSFrance
to Total Specific Solutions
B&B
Active
HospitalityFrance· 2010

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK

Questions

Who owns hutchmed?

hutchmed is currently owned by The Carlyle Group and General Atlantic, through Carlyle Asia Partners III.

Who has owned hutchmed over time?

hutchmed has been through 2 private-equity ownership periods: The Carlyle Group · via Carlyle Asia Partners III; General Atlantic.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue